Got a tip?:

Posts Tagged ‘Morgan Stanley’

Teva Pharmaceuticals is Considered a Buy Finally by Morgan Stanley

Investment bank Morgan Stanley has given Israel’s Teva Pharmaceuticals a positive rating for the first time in two years. Morgan Stanley analyst David Risinger says investors should buy shares of Teva Pharmaceutical Industries as the pharmaceutical giant’s turnaround picks up steam. Risinger upgraded shares of Teva from “equal weight” to “overweight” and increased his price…

Read More

This is Why Morgan Stanley Raised its Price Target for Salesforce

Salesforce gained some bullish sentiment from Morgan Stanley this month, and a new price target too. The firm has raised its price target on Salesforce shares to $178 from $153 and is optimistic over the company’s recent deal with MuleSoft. Morgan Stanley is predicting that the company will see a large increase in its sales…

Read More